Hemorrhagic Shock clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

    Sorry, not currently recruiting here

    The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood transfusion. The primary objective of the clinical trial is to determine the effectiveness of Low Titer Group O Whole Blood (LTOWB) compared to component therapy (CT), and Tranexamic Acid (TXA) compared to placebo in decreasing 24-hour all-cause mortality in children with traumatic life threatening hemorrhage.

    at UC Davis

Our lead scientists for Hemorrhagic Shock research studies include .

Last updated: